0001209191-21-008655.txt : 20210208 0001209191-21-008655.hdr.sgml : 20210208 20210208205049 ACCESSION NUMBER: 0001209191-21-008655 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210208 FILED AS OF DATE: 20210208 DATE AS OF CHANGE: 20210208 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Shameze Rampertab CENTRAL INDEX KEY: 0001721810 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19437 FILM NUMBER: 21603489 MAIL ADDRESS: STREET 1: C/O ZOMEDICA PHARMACEUTICALS CORP. STREET 2: 3928 VARSITY DRIVE CITY: ANN ARBOR STATE: MI ZIP: 48108 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: TRANSENTERIX, INC. CENTRAL INDEX KEY: 0000876378 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 112962080 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 635 DAVIS DRIVE STREET 2: SUITE 300 CITY: MORRISVILLE STATE: NC ZIP: 27560 BUSINESS PHONE: 919-765-8400 MAIL ADDRESS: STREET 1: 635 DAVIS DRIVE STREET 2: SUITE 300 CITY: MORRISVILLE STATE: NC ZIP: 27560 FORMER COMPANY: FORMER CONFORMED NAME: TRANSENTERIX INC. DATE OF NAME CHANGE: 20131210 FORMER COMPANY: FORMER CONFORMED NAME: SafeStitch Medical, Inc. DATE OF NAME CHANGE: 20080211 FORMER COMPANY: FORMER CONFORMED NAME: CELLULAR TECHNICAL SERVICES CO INC DATE OF NAME CHANGE: 19930328 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2021-02-08 0 0000876378 TRANSENTERIX, INC. TRXC 0001721810 Shameze Rampertab 635 DAVIS DRIVE SUITE 300 MORRISVILLE NC 27560 0 1 0 0 EVP, Chief Financial Officer Stock Options 4.21 2021-02-08 4 A 0 73078 0.00 A 2028-02-08 Common Stock 73078 73078 D Restricted Stock Units 0.00 2021-02-08 4 A 0 59112 0.00 A Common Stock 59112 59112 D Restricted Stock Units 0.00 2021-02-08 4 A 0 59112 0.00 A Common Stock 59112 59112 D Restricted Stock Units 0.00 2021-02-08 4 A 0 59200 0.00 A Common Stock 59200 59200 D Award subject to forfeiture if the Registrant's stockholders do not approve an increase in the number of shares available under the Plan at the Registrant's 2021 annual meeting of stockholders. Vests one-third annually on each of February 4, 2022, 2023 and 2024, subject to acceleration as set forth in the Registrant's Amended and Restated Incentive Compensation Plan ("Plan") and the Reporting Person's Employment Agreement with the Registrant ("Employment Agreement"). Each restricted stock unit ("RSU") represents the right to receive one share of the Registrant's common stock. Forfeiture restrictions will lapse on the RSUs in three equal installments of 19,704 on each of February 4, 2022, 2023 and 2024, as long as the Reporting Person remains in continuous service during the vesting period, subject to acceleration as set forth in the Plan and the Employment Agreement. Each performance-based restricted stock unit ("PRSU") represents the right to receive one share of the Registrant's common stock. PRSU award with time-based vesting in three equal installments of 19,704 on each of February 4, 2022, 2023 and 2024, and performance-based vesting only if, designated corporate goals are met. Represents a discretionary retention bonus. Forfeiture restrictions will lapse on the RSUs on February 4, 2022, as long as the Reporting Person remains in continuous service during the vesting period. /s/ Joshua Weingard, as attorney-in-fact for Shameze Rampertab 2021-02-08